Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Chronic Heart Failure

Free Subscription 15.12.2025 6 Am J Cardiol 1 Basic Res Cardiol 2 Cardiovasc Res 1 Circ Heart Fail 1 Circ Res 1 Clin Cardiol 3 Eur Heart J 2 Eur J Heart Fail 1 Heart 2 Int J Cardiol 1 J Am Coll Cardiol 4 J Card Fail 2 J Cardiol 3 J Cardiovasc Pharmacol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. ECHARTE-MORALES J, Torrado J, Scotti A, Sturla M, et al
   Natural History of Atrial versus Ventricular Secondary Tricuspid Regurgitation: Insights from the Bronx-Valve Registry.
   Am J Cardiol. 2025 Oct 17:S0002-9149(25)00642.
   PubMed         Abstract available
   
   
2. DI PIETRO G, Improta R, De Filippo O, Bruno F, et al
   Systematic Review and Meta-analysis of Short-Term Outcomes in Patients Following Protected High-Risk PCI.
   Am J Cardiol. 2025 Oct 3:S0002-9149(25)00556.
   PubMed         Abstract available
   
   
3. FELDMAN D, Grohol B, Mack V, Langston M, et al
   Effects of Renin-Angiotensin-Aldosterone System Inhibitor Discontinuation After Acute Kidney Injury on Mortality: A Retrospective Analysis.
   Am J Cardiol. 2025;257:178-182.
   PubMed         Abstract available
   
   
4. SVANSTROM H, Mkoma GF, Hviid A, Pasternak B, et al
   Angiotensin Receptor-Neprilysin Inhibitors and Mortality Among Patients With HFrEF.
   Am J Cardiol. 2026;258:158-164.
   PubMed         Abstract available
   
   
5. CAI J, Parker L, Bhargav R, Maganti K, et al
   Strategic Approach Towards the Evaluation of HeartMate 3 Left Ventricular Assist Devices Using Multimodality Imaging.
   Am J Cardiol. 2026;258:100-111.
   PubMed         Abstract available
   
   
6. JERING KS, Claggett BL, Amir O, Cikes M, et al
   Differences in Characteristics and Clinical Outcomes According to Age in Patients Following High-Risk Myocardial Infarction - Insights from PARADISE-MI.
   Am J Cardiol. 2025 Aug 6:S0002-9149(25)00439.
   PubMed         Abstract available
   
   

   
   Basic Res Cardiol

7. LI Z, Sun X, Wang Y, Zhang F, et al
   Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP-P2X7-NLRP3 inflammasome axis.
   Basic Res Cardiol. 2025;120:1225-1247.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

8. SILVA ED, Tome I, Vasques-Novoa F, Conceicao G, et al
   Pharmacological clearance of senescent cells reduces inflammation, endothelial damage and cardiac fibrosis in HFpEF.
   Cardiovasc Res. 2025;121:2385-2403.
   PubMed         Abstract available
   
   
9. RAMOVS V, Chen HS, Patra A, Tjokrodirijo R, et al
   KLHL24 mutation drives intermediate filament degradation, mitochondrial dysfunction and fibrosis in heart failure patients.
   Cardiovasc Res. 2025 Dec 5:cvaf231. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

10. BELLUMKONDA L, Khawaja T, Al-Kindi S, Khraishah H, et al
    Air Pollution and Exposomic Impacts on Heart Failure.
    Circ Heart Fail. 2025 Dec 5:e013338. doi: 10.1161/CIRCHEARTFAILURE.125.013338.
    PubMed         Abstract available
    
    

    
    Circ Res

11. CHEN M, Wang Z, Li J, Teng P, et al
    Histone Lactylation Promotes Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure by Regulating TGFB2 Expression.
    Circ Res. 2025 Dec 11. doi: 10.1161/CIRCRESAHA.125.326185.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

12. AHMED M, Burhan M, Shafiq A, Hashmi TM, et al
    GLP-1 and Dual GLP-1/GIP Receptor Agonists in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Clin Cardiol. 2025;48:e70234.
    PubMed         Abstract available
    
    

    
    Eur Heart J

13. LAM CSP, Lu Y, Tay WT
    Heart failure and economic resilience: why China's decade-long projection matters.
    Eur Heart J. 2025 Dec 12:ehaf901. doi: 10.1093.
    PubMed        
    
    
14. WANG H, Zhou H, Chai K, Yan S, et al
    Heart failure in China: a macroeconomic modelling study of intervention strategies.
    Eur Heart J. 2025 Dec 8:ehaf992. doi: 10.1093.
    PubMed         Abstract available
    
    
15. SHECHTER A, Shechter M
    Magnesium in heart failure: an old ion with new lessons.
    Eur Heart J. 2025 Dec 5:ehaf955. doi: 10.1093.
    PubMed        
    
    

    
    Eur J Heart Fail

16. FIORETTI F, Praderio A, Nodari S, Metra M, et al
    Combination diuretic therapy in acute heart failure: A systematic review and meta-analysis.
    Eur J Heart Fail. 2025 Dec 10. doi: 10.1002/ejhf.70094.
    PubMed         Abstract available
    
    
17. ABDIN A, Bauersachs J, Abdelhamid M, Aktaa S, et al
    Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document.
    Eur J Heart Fail. 2025 Dec 11. doi: 10.1002/ejhf.70087.
    PubMed         Abstract available
    
    

    
    Heart

18. ZAGHI A, Jujic A, Zilic H, Dieden A, et al
    Impact of cerebral oxygen saturation on mortality and rehospitalisation in patients with heart failure and the role of physical activity as a modifying factor: the HARVEST-Malmo Study.
    Heart. 2025 Dec 9:heartjnl-2025-326503. doi: 10.1136/heartjnl-2025-326503.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

19. OZAKI Y, Uemura Y, Kondo T, Kazama S, et al
    Pulmonary artery Pulsatility index and compliance for hemodynamic risk classification in heart failure.
    Int J Cardiol. 2025;445:134079.
    PubMed         Abstract available
    
    
20. DUDDA J, Behnes M, Weidner K, Lau F, et al
    Platelet counts and prognosis in heart failure with mildly reduced ejection fraction: Results from a large-scaled registry.
    Int J Cardiol. 2025 Dec 9:134088. doi: 10.1016/j.ijcard.2025.134088.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

21. OSTROMINSKI JW, Neuen BL, Claggett BL, Filippatos G, et al
    Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes.
    J Am Coll Cardiol. 2025 Nov 18:S0735-1097(25)10071.
    PubMed        
    
    

    
    J Card Fail

22. ZONNEVELD LEEC, Damman K, Costanzo MR, Voors AA, et al
    Current Pharmacological and Non-Pharmacological Decongestion Strategies in Acute Heart Failure - Evidence and Practical Guidance.
    J Card Fail. 2025 Dec 10:S1071-9164(25)01040.
    PubMed         Abstract available
    
    
23. BELDHUIS IE, Ter Maaten JM, van der Meer P, Coster JE, et al
    Corrigendum to "Individual Natriuretic and Diuretic Response in Acute Heart Failure: Insights from the PUSH-AHF Pharmacologic Substudy", Journal of Cardiac Failure volume 31 (2025) P1578-1581/ PMID: 40414278.
    J Card Fail. 2025 Dec 8:S1071-9164(25)00995.
    PubMed        
    
    
24. ALMUFLEH A, Brahmbhatt DH, Billia F, Clarke B, et al
    The Canadian Heart Failure Society (CHFS) Workforce Committee Report 2024: Addressing the Challenges Facing the Heart Failure Physicians Workforce in Canada CHFS 2024 Heart Failure Workforce Report.
    J Card Fail. 2025 Dec 3:S1071-9164(25)01028.
    PubMed         Abstract available
    
    
25. EZEKOWITZ JA, Mulder H, Mentz RJ, Butler J, et al
    Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial.
    J Card Fail. 2025;31:1822-1833.
    PubMed         Abstract available
    
    

    
    J Cardiol

26. NAKAO K, Nishimura K, Shishido T, Nakao YM, et al
    Trends and factors associated with potentially inappropriate medication use in older adults hospitalized for heart failure: A nationwide analysis using the JROAD-DPC database.
    J Cardiol. 2025 Dec 11:S0914-5087(25)00300-4. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available
    
    
27. NAKAMURA M, Imamura T, Nakagaito M, Matsumiya G, et al
    Gender difference and outcomes in HeartMate 3 left ventricular assist device support: Results from the J-MACS registry.
    J Cardiol. 2025;86:525-532.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

28. ELAD B, Lotan D, Richter I, Changhee L, et al
    Effect of Vericiguat on Pulmonary Artery Pressures in Heart Failure Patients: Real-World Insights from Pressure Sensor Monitoring.
    J Cardiovasc Pharmacol. 2025 Dec 11. doi: 10.1097/FJC.0000000000001761.
    PubMed         Abstract available
    
    
29. BERNARDI M, Golino M, Spadafora L, Sarto G, et al
    Current Challenges for the Diagnosis of HFpEF and Possible Simplification of the Diagnostic Approach.
    J Cardiovasc Pharmacol. 2025;86:522-534.
    PubMed         Abstract available
    
    
30. SONG C, Tang Q, Liu L, Zhou G, et al
    CDK Inhibitor R547 Attenuates Pressure Overload-Induced Cardiac Hypertrophy Through PI3K/AKT and TGF-beta/Smad3 Signaling Pathways.
    J Cardiovasc Pharmacol. 2025;86:557-564.
    PubMed         Abstract available
    
    

    
    PLoS One

31. ZHAO L, Zhang J, Liu W, Dai C, et al
    GV effects of diabetes mellitus on clinical outcomes of patients with acute heart failure: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0338653.
    PubMed         Abstract available
    
    
32. KOKORELIAS KM, Hoang P, Harris MT
    Who gets included? A scoping review protocol of digital health interventions for older adults with heart failure through an equity lens.
    PLoS One. 2025;20:e0337990.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.